DANIEL A. PRYOR - 02 Nov 2021 Form 4 Insider Report for Colfax CORP (ENOV)

Role
EVP, Strategy & Business Dev.
Signature
/s/ Bradley Tandy, Attorney-in-Fact
Issuer symbol
ENOV
Transactions as of
02 Nov 2021
Net transactions value
-$6,346
Form type
4
Filing time
04 Nov 2021, 18:00:14 UTC
Next filing
08 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $.001 Options Exercise $329,807 +6,340 +3.9% $52.02 170,597 02 Nov 2021 Direct
transaction ENOV Common stock, par value $.001 Sale $336,153 -6,340 -3.7% $53.02 164,257 02 Nov 2021 Direct F1, F2
holding ENOV Common stock, par value $.001 2,312 02 Nov 2021 By 401K Plan
holding ENOV Common stock, par value $.001 1,000 02 Nov 2021 By trust for daughter
holding ENOV Common stock, par value $.001 1,000 02 Nov 2021 By trust for daughter
holding ENOV Common stock, par value $.001 1,000 02 Nov 2021 By trust for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENOV Employee Stock Option (right to buy) Options Exercise $0 -6,340 -5.4% $0.000000 111,670 02 Nov 2021 Common stock, par value $.001 6,340 $52.02 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.06, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.